# Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial

> **NCT01796678** · PHASE2 · COMPLETED · sponsor: **UCSF Benioff Children's Hospital Oakland** · enrollment: 56 (actual)

## Conditions studied

- Vaso-occlusive Pain Episodes

## Interventions

- **DRUG:** Arginine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01796678
- **Lead sponsor:** UCSF Benioff Children's Hospital Oakland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2013-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01796678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01796678, "Arginine Therapy in Sickle Cell Disease-VOC Clinical Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01796678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*